http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-5390083-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89ff5d6c1af34ea5318c58fc89b8a363 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-417 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 |
| filingDate | 2002-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_048312d9c87a8c25cffdc393f489d620 |
| publicationDate | 2004-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CO-5390083-A1 |
| titleOfInvention | COMBINATION THERAPY TO MODULATE THE HUMAN SEXUAL RESPONSE |
| abstract | A composition comprising an orally administrable capsule comprising phentolamine and apomorphine, and optionally a pharmaceutically acceptable carrier. The composition of claim 1 comprising from about 0.25 mg to about 10 mg of apomorphine.The composition of claim 2 comprising about 2 mg of apomorphine.The composition of claim 2 comprising about 3 mg of apomorphine. Composition of claim 2 comprising approximately 4 mg of apomorphine.The composition of claim 1 wherein the phentolamine is selected from the group consisting of phentolamine, phentolamine hydrochloride, and phentolamine mesylate. |
| priorityDate | 2002-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 15.